Aloysius Ho

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

Dietger Niederwieser, Helen Baldomero, Nosa Bazuaye et al. · Haematologica · 2021 · 221 citations · Full text

Transplantation Medicine, Immunology, Stem Cell Transplantation +20

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

Aloysius Ho, Antonio Pagliuca, Michelle Kenyon et al. · Blood · 2004 · 202 citations · Full text

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

Judith Marsh, Vikas Gupta, ZiYi Lim et al. · Blood · 2011 · 166 citations · Full text

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Rowena D. Faulkner, Charles Craddock, Prem Mahendra et al. · Blood · 2003 · 166 citations · Full text

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

Kavita Raj, A M John, Aloysius Ho et al. · Leukemia · 2007 · 147 citations

Chromatin, Genetic Disorder, Medicine +8